Low-dose salinomycin induces anti-leukemic responses in AML and MLL.
Roulston GD, Burt CL, Kettyle LM, Matchett KB, Keenan HL, Mulgrew NM, Ramsey JM, Dougan C, McKiernan J, Grishagin IV, Mills KI, Thompson A.
Roulston GD, et al. Among authors: mills ki.
Oncotarget. 2016 Nov 8;7(45):73448-73461. doi: 10.18632/oncotarget.11866.
Oncotarget. 2016.
PMID: 27612428
Free PMC article.